Literature DB >> 11354284

Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma.

M Minata1, N Nishida, T Komeda, H Azechi, H Katsuma, T Nishimura, M Kuno, T Ito, Y Yamamoto, I Ikai, Y Yamaoka, Y Fukuda, K Nakao.   

Abstract

BACKGROUND: We tested for the presence of alpha-fetoprotein (AFP) mRNA by using nested RT-PCR in the peripheral blood of hepatocellular carcinoma (HCC) patients who had undergone curative surgery, and investigated the occurrence of intrahepatic and/or extrahepatic metastasis thereafter, to reveal the optimal timing of blood sampling for the prediction of metastatic recurrence.
METHODS: Twenty-nine patients with HCC, who had been operated on were analyzed with RT-PCR at several points during the clinical course, and examined for metastatic recurrence for 3-28 months (mean = 18.7 months) after surgery.
RESULTS: The presence of AFP mRNA before surgery was significantly correlated with the tumor size (P = 0.017). Metastatic recurrence was associated with the postoperative detection of AFP mRNA (P < 0.001), but not with the preoperative and/or perioperative detection. Furthermore, AFP mRNA was detected in some cases that showed low serum AFP levels at recurrence. The recurrence-free period after the detection of AFP mRNA varied from 1 to 12 months.
CONCLUSIONS: The postoperative detection of AFP mRNA is useful for the prediction of metastatic recurrence, and long-term follow up with this method should be conducted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354284     DOI: 10.1046/j.1440-1746.2001.02461.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  12 in total

1.  Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma.

Authors:  Umberto Cillo; Alessandro Vitale; Filippo Navaglia; Daniela Basso; Umberto Montin; Marco Bassanello; Francesco D'Amico; Francesco Antonio Ciarleglio; Alberto Brolese; Giacomo Zanus; Vito De Pascale; Mario Plebani; Davide Francesco D'Amico
Journal:  World J Gastroenterol       Date:  2005-11-28       Impact factor: 5.742

Review 2.  Predictive biomarkers of antiangiogenic therapy for advanced hepatocellular carcinoma: where are we?

Authors:  Yu-Yun Shao; Chih-Hung Hsu; Ann-Lii Cheng
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

3.  The Clinical Significance of Alpha-Fetoprotein mRNAs in Patients with Hepatocellular Carcinoma.

Authors:  Shogo Kobayashi; Akira Tomokuni; Hidenori Takahashi; Hirofumi Akita; Keijiro Sugimura; Norikatsu Miyoshi; Jeong Ho Moon; Masayoshi Yasui; Takeshi Omori; Masayuki Ohue; Yoshiyuki Fujiwara; Masahiko Yano; Masato Sakon
Journal:  Gastrointest Tumors       Date:  2017-02-08

4.  Association between recurrence of hepatocellular carcinoma and alpha-fetoprotein messenger RNA levels in peripheral blood.

Authors:  Osakuni Morimoto; Hiroaki Nagano; Atsushi Miyamoto; Yoshiyuki Fujiwara; Motoi Kondo; Tameyoshi Yamamoto; Hideo Ota; Masato Nakamura; Hiroshi Wada; Bazarragchaa Damdinsuren; Shigeru Marubashi; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Morito Monden
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

Review 5.  Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Xiang Ding; Lian-Yue Yang; Geng-Wen Huang; Jian-Qing Yang; He-Li Liu; Wei Wang; Ji-Xiang Peng; Jie-Quan Yang; Yi-Ming Tao; Zhi-Gang Chang; Xiu-Shou Ling
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

Review 6.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 7.  Serum tumor markers for detection of hepatocellular carcinoma.

Authors:  Lin Zhou; Jia Liu; Feng Luo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 8.  Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-17       Impact factor: 4.553

9.  Circulating tumor cells measurements in hepatocellular carcinoma.

Authors:  Franck Chiappini
Journal:  Int J Hepatol       Date:  2012-05-28

10.  Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma.

Authors:  Shu-Wen Cheng; Hung-Wen Tsai; Yih-Jyh Lin; Pin-Nan Cheng; Yu-Chung Chang; Chia-Jui Yen; Hsuan-Pang Huang; Yun-Pei Chuang; Ting-Tsung Chang; Chung-Ta Lee; Anning Chao; Cheng-Yang Chou; Shih-Huang Chan; Nan-Haw Chow; Chung-Liang Ho
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.